5000万，“保健品一哥”投了家AI芯片公司
Quick Answer
Tao Chen Beijian, a leading health supplement company in China, announced a 50 million yuan investment in an AI chip company on June 18.
Quick Take
This strategic move highlights the growing intersection of health and technology sectors, as companies seek to leverage AI advancements for better product development.
Key Points
- Tao Chen Beijian is investing 50 million yuan in an AI chip firm.
- The investment aims to enhance product development through AI technology.
- This move signifies a trend of health companies integrating tech innovations.
- The announcement was made on June 18, 2023.
- AI advancements are increasingly relevant in the health supplement sector.
Article Excerpt
From source RSS / original summary芯东西（公众号：aichip001） 作者| ZeR0 编辑| 漠影. 芯东西6月22日报道，6月18日，国内“保健品一哥”汤臣倍健发布公告，宣布拟以自有资金5000万元投资
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from WebSearch (Tavily)
See more →全球AI芯片峰会，9月上海见！
The 2026 Global AI Chip Summit will take place in Shanghai on September 22-23, focusing on the evolving AI chip landscape, including the shift from training to inference, the rise of diverse chip technologies, and the restructuring of industry competition. Notable speakers include experts from leading universities and companies, discussing advancements in AI chip architecture and applications.